PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab -paclitaxel (FA) and nab -paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development
Grose, Derek B., McKay, Colin J, Cooke, Susie, Graham, Janet Shirley, Duthie, Fraser, Jamieson, Nigel, Ravikumar, Reena, Duffton, Aileen, McIntosh, David, Goody, Rebecca, Radhakrishna, Ganesh, Hawkins, Maria A, Colville, Dave, Willshire, Christine, Stobo, Jon, Paul, James, Bradley, Sarah, Dixon-Hughes, Judith, Biankin, Andrew Victor, Chang, David Kuang-Fu
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Dual isotope subtraction SPECT-CT in the diagnosis of primary hyperparathyroidism
Tutty, Anna-May, Bolster, Alison, Neilly, James, Han, Sai, Poon, Fat Wui, Colville, Dave, Shand, John
Published in Physica medica (01.02.2016)
Published in Physica medica (01.02.2016)
Get full text
Journal Article